Characterization of PPAR dual ligand MCC-555 in AOM-induced colorectal tumorigenesis.

Characterization of PPAR dual ligand MCC-555 in AOM-induced colorectal tumorigenesis.
复制标题

DOI:
10.1016/j.etp.2013.01.005
复制
发表时间:
2013-09
期刊:
Experimental and toxicologic pathology : official journal of the Gesellschaft fur Toxikologische Pathologie
影响因子:
--
通讯作者:
Baek SJ
Baek SJ
中科院分区:
其他
文献类型:
--
作者:
Imchen T;Manasse J;Min KW;Baek SJ

文献摘要

参考文献

被引文献

相似文献

结直肠癌(CRC)是最常见的诊断癌症之一。过氧化物酶体增殖物激活受体γ(过氧化物酶体增殖物激活受体γ,PPARγ)激动剂通过影响细胞增殖、分化和凋亡而代表用于癌症治疗的潜在重要的化学预防/治疗化合物家族。已开发出PPARα和PPARγ的双配体,如奈格列酮(MCC-555),用于改善代谢综合征(包括高血糖症和高脂血症)的治疗。有趣的是,这些双重配体还具有针对多种癌细胞系的抗增殖活性,其效力大于常规的PPARγ特异性配体。在这项研究中,使用氧化偶氮甲烷(AOM)诱导的A/J小鼠结肠异常隐窝灶(ACF)评价MCC-555在结直肠肿瘤发生中的化学预防特性。我们发现,与对照组相比,MCC-555抑制A/J小鼠中AOM诱导的ACF。MCC-555给药导致结肠中有丝分裂减少和凋亡细胞增加。此外,肿瘤抑制蛋白MUC 2的表达在MCC-555处理的小鼠中增加。我们的数据清楚地表明,MCC-555对结肠癌发生的早期事件有影响,从而提供了MCC-555可能是CRC的潜在预防化合物的证据。
Colorectal cancer (CRC) is one of the most commonly diagnosed cancers. Peroxisome proliferator-activated receptor γ (PPARγ) agonists represent a potentially important family of chemopreventive/therapeutic compounds for cancer treatment by affecting cell proliferation, differentiation, and apoptosis. Dual ligands for PPARα and PPARγ, such as netoglitazone (MCC-555), have been developed to improve treatment of metabolic syndromes, including hyperglycemia and hyperlipidemia. Interestingly, these dual ligands also possess anti-proliferative activities against a variety of cancer cell lines with a greater potency than conventional PPARγ specific ligands. In this study, chemopreventive properties of MCC-555 in colorectal tumorigenesis were evaluated using azoxymethane (AOM)-induced colonic aberrant crypt foci (ACF) in A/J mice. We found that MCC-555 suppressed AOM-induced ACF in A/J mice, compared to the control group. Administration of MCC-555 resulted in decreased mitoses and increased apoptotic cells in the colon. Furthermore, expression of tumor suppressor protein MUC2 was increased in MCC-555 treated mice. Our data clearly suggest that MCC-555 has an effect on the early events of colon carcinogenesis, thus providing evidence that MCC-555 could be a potential preventive compound for CRC.
DOI: 10.1083/jcb.200311021
发表时间: 2004-07-05
期刊: The Journal of cell biology
影响因子: --
作者:
Blache P;van de Wetering M;Duluc I;Domon C;Berta P;Freund JN;Clevers H;Jay P
通讯作者: Jay P
DOI: 10.1158/1535-7163.mct-07-0022
发表时间: 2007-05-01
影响因子: 5.7
作者:
Chintharlapalli, Sudhakar;Papineni, Sabitha;Safe, Stephen
通讯作者: Safe, Stephen
DOI: 10.1111/j.1365-2443.2004.00793.x
发表时间: 2004-11-01
期刊: GENES TO CELLS
影响因子: 2.1
作者:
Rumi, MAK;Ishihara, S;Kinoshita, Y
通讯作者: Kinoshita, Y
DOI: 10.1002/ijc.21719
发表时间: 2006-06-15
影响因子: 6.4
作者:
Kohno, Hiroyuki;Suzuki, Rikako;Tanaka, Takuji
通讯作者: Tanaka, Takuji